Last reviewed · How we verify

Benzalkonium Chloride-Benzocaine Topical

Medice Arzneimittel Pütter GmbH & Co KG · FDA-approved active Small molecule

Benzalkonium Chloride-Benzocaine Topical is a Topical antimicrobial-anesthetic combination Small molecule drug developed by Medice Arzneimittel Pütter GmbH & Co KG. It is currently FDA-approved for Minor cuts, wounds, and abrasions requiring antiseptic and anesthetic treatment, Topical pain relief with antimicrobial protection. Also known as: triple combination.

Benzalkonium chloride acts as an antimicrobial agent while benzocaine provides local anesthetic effects through sodium channel blockade.

Benzalkonium chloride acts as an antimicrobial agent while benzocaine provides local anesthetic effects through sodium channel blockade. Used for Minor cuts, wounds, and abrasions requiring antiseptic and anesthetic treatment, Topical pain relief with antimicrobial protection.

At a glance

Generic nameBenzalkonium Chloride-Benzocaine Topical
Also known astriple combination
SponsorMedice Arzneimittel Pütter GmbH & Co KG
Drug classTopical antimicrobial-anesthetic combination
TargetBacterial cell membranes (benzalkonium); sodium channels (benzocaine)
ModalitySmall molecule
Therapeutic areaDermatology / Topical antisepsis
PhaseFDA-approved

Mechanism of action

Benzalkonium chloride is a quaternary ammonium compound that disrupts bacterial cell membranes, providing antiseptic/antimicrobial activity. Benzocaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing pain signal transmission. Together, this combination provides both antimicrobial protection and topical pain relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Benzalkonium Chloride-Benzocaine Topical

What is Benzalkonium Chloride-Benzocaine Topical?

Benzalkonium Chloride-Benzocaine Topical is a Topical antimicrobial-anesthetic combination drug developed by Medice Arzneimittel Pütter GmbH & Co KG, indicated for Minor cuts, wounds, and abrasions requiring antiseptic and anesthetic treatment, Topical pain relief with antimicrobial protection.

How does Benzalkonium Chloride-Benzocaine Topical work?

Benzalkonium chloride acts as an antimicrobial agent while benzocaine provides local anesthetic effects through sodium channel blockade.

What is Benzalkonium Chloride-Benzocaine Topical used for?

Benzalkonium Chloride-Benzocaine Topical is indicated for Minor cuts, wounds, and abrasions requiring antiseptic and anesthetic treatment, Topical pain relief with antimicrobial protection.

Who makes Benzalkonium Chloride-Benzocaine Topical?

Benzalkonium Chloride-Benzocaine Topical is developed and marketed by Medice Arzneimittel Pütter GmbH & Co KG (see full Medice Arzneimittel Pütter GmbH & Co KG pipeline at /company/medice-arzneimittel-p-tter-gmbh-co-kg).

Is Benzalkonium Chloride-Benzocaine Topical also known as anything else?

Benzalkonium Chloride-Benzocaine Topical is also known as triple combination.

What drug class is Benzalkonium Chloride-Benzocaine Topical in?

Benzalkonium Chloride-Benzocaine Topical belongs to the Topical antimicrobial-anesthetic combination class. See all Topical antimicrobial-anesthetic combination drugs at /class/topical-antimicrobial-anesthetic-combination.

What development phase is Benzalkonium Chloride-Benzocaine Topical in?

Benzalkonium Chloride-Benzocaine Topical is FDA-approved (marketed).

What are the side effects of Benzalkonium Chloride-Benzocaine Topical?

Common side effects of Benzalkonium Chloride-Benzocaine Topical include Local irritation or sensitization, Allergic contact dermatitis, Burning or stinging at application site.

What does Benzalkonium Chloride-Benzocaine Topical target?

Benzalkonium Chloride-Benzocaine Topical targets Bacterial cell membranes (benzalkonium); sodium channels (benzocaine) and is a Topical antimicrobial-anesthetic combination.

Related